These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 24127042)

  • 1. Pathways of Toxicity.
    Kleensang A; Maertens A; Rosenberg M; Fitzpatrick S; Lamb J; Auerbach S; Brennan R; Crofton KM; Gordon B; Fornace AJ; Gaido K; Gerhold D; Haw R; Henney A; Ma'ayan A; McBride M; Monti S; Ochs MF; Pandey A; Sharan R; Stierum R; Tugendreich S; Willett C; Wittwehr C; Xia J; Patton GW; Arvidson K; Bouhifd M; Hogberg HT; Luechtefeld T; Smirnova L; Zhao L; Adeleye Y; Kanehisa M; Carmichael P; Andersen ME; Hartung T
    ALTEX; 2014; 31(1):53-61. PubMed ID: 24127042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementing Toxicity Testing in the 21st Century (TT21C): Making safety decisions using toxicity pathways, and progress in a prototype risk assessment.
    Adeleye Y; Andersen M; Clewell R; Davies M; Dent M; Edwards S; Fowler P; Malcomber S; Nicol B; Scott A; Scott S; Sun B; Westmoreland C; White A; Zhang Q; Carmichael PL
    Toxicology; 2015 Jun; 332():102-11. PubMed ID: 24582757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards tailored assays for cell-based approaches to toxicity testing.
    Rossini GP; Hartung T
    ALTEX; 2012; 29(4):359-72. PubMed ID: 23138507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mechanistic redefinition of adverse effects - a key step in the toxicity testing paradigm shift.
    Boekelheide K; Andersen ME
    ALTEX; 2010; 27(4):243-52. PubMed ID: 21240467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of new technologies to characterization and prediction of adverse effects.
    Rouquié D; Heneweer M; Botham J; Ketelslegers H; Markell L; Pfister T; Steiling W; Strauss V; Hennes C
    Crit Rev Toxicol; 2015 Feb; 45(2):172-83. PubMed ID: 25615431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relevance and Application of Read-Across - Mini Review of European Consensus Platform for Alternatives and Scandinavian Society for Cell Toxicology 2017 Workshop Session.
    Stuard SB; Heinonen T
    Basic Clin Pharmacol Toxicol; 2018 Sep; 123 Suppl 5():37-41. PubMed ID: 29524304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From Classical Toxicology to Tox21: Some Critical Conceptual and Technological Advances in the Molecular Understanding of the Toxic Response Beginning From the Last Quarter of the 20th Century.
    Choudhuri S; Patton GW; Chanderbhan RF; Mattia A; Klaassen CD
    Toxicol Sci; 2018 Jan; 161(1):5-22. PubMed ID: 28973688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The human toxome project.
    Bouhifd M; Andersen ME; Baghdikian C; Boekelheide K; Crofton KM; Fornace AJ; Kleensang A; Li H; Livi C; Maertens A; McMullen PD; Rosenberg M; Thomas R; Vantangoli M; Yager JD; Zhao L; Hartung T
    ALTEX; 2015; 32(2):112-24. PubMed ID: 25742299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A critical appraisal of the process of regulatory implementation of novel in vivo and in vitro methods for chemical hazard and risk assessment.
    Piersma AH; Ezendam J; Luijten M; Muller JJ; Rorije E; van der Ven LT; van Benthem J
    Crit Rev Toxicol; 2014 Nov; 44(10):876-94. PubMed ID: 25058877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel strategies for toxicological risk assessments.
    Roy A; Akbarsha MA
    ALTEX; 2014; 31(1):91-3. PubMed ID: 24448760
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of biomarkers of toxicity for integrating in vitro hazard estimates into risk assessment for humans.
    Blaauboer BJ; Boekelheide K; Clewell HJ; Daneshian M; Dingemans MM; Goldberg AM; Heneweer M; Jaworska J; Kramer NI; Leist M; Seibert H; Testai E; Vandebriel RJ; Yager JD; Zurlo J
    ALTEX; 2012; 29(4):411-25. PubMed ID: 23138511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated Testing Strategy (ITS) - Opportunities to better use existing data and guide future testing in toxicology.
    Jaworska J; Hoffmann S
    ALTEX; 2010; 27(4):231-42. PubMed ID: 21240466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accelerating the development of 21st-century toxicology: outcome of a Human Toxicology Project Consortium workshop.
    Stephens ML; Barrow C; Andersen ME; Boekelheide K; Carmichael PL; Holsapple MP; Lafranconi M
    Toxicol Sci; 2012 Feb; 125(2):327-34. PubMed ID: 21948868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SEURAT: Safety Evaluation Ultimately Replacing Animal Testing--recommendations for future research in the field of predictive toxicology.
    Daston G; Knight DJ; Schwarz M; Gocht T; Thomas RS; Mahony C; Whelan M
    Arch Toxicol; 2015 Jan; 89(1):15-23. PubMed ID: 25433540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advancing alternatives analysis: The role of predictive toxicology in selecting safer chemical products and processes.
    Malloy T; Zaunbrecher V; Beryt E; Judson R; Tice R; Allard P; Blake A; Cote I; Godwin H; Heine L; Kerzic P; Kostal J; Marchant G; McPartland J; Moran K; Nel A; Ogunseitan O; Rossi M; Thayer K; Tickner J; Whittaker M; Zarker K
    Integr Environ Assess Manag; 2017 Sep; 13(5):915-925. PubMed ID: 28247928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental toxicology: new directions workshop: refining testing strategies and study designs.
    Brannen KC; Fenton SE; Hansen DK; Harrouk W; Kim JH; Shuey D
    Birth Defects Res B Dev Reprod Toxicol; 2011 Oct; 92(5):404-12. PubMed ID: 22006510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel technologies and an overall strategy to allow hazard assessment and risk prediction of chemicals, cosmetics, and drugs with animal-free methods.
    Leist M; Lidbury BA; Yang C; Hayden PJ; Kelm JM; Ringeissen S; Detroyer A; Meunier JR; Rathman JF; Jackson GR; Stolper G; Hasiwa N
    ALTEX; 2012; 29(4):373-88. PubMed ID: 23138508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-animal assessment of skin sensitization hazard: Is an integrated testing strategy needed, and if so what should be integrated?
    Roberts DW; Patlewicz G
    J Appl Toxicol; 2018 Jan; 38(1):41-50. PubMed ID: 28543848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of mechanistic and pharmacokinetic data for risk assessment at the National Institute of Environmental Health Sciences (NIEHS).
    Schwetz BA
    Toxicol Lett; 1995 Sep; 79(1-3):29-32. PubMed ID: 7570667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathway-based toxicity: history, current approaches and liver fibrosis and steatosis as prototypes.
    Willett C; Caverly Rae J; Goyak KO; Landesmann B; Minsavage G; Westmoreland C
    ALTEX; 2014; 31(4):407-21. PubMed ID: 24954301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.